Pancreas
I. Acute Pancreatitis
a. Pathology: most commonly gallstone obstruction; how EtOH causes it is unknown; ischemia after abdominal surgery (commonly gastric and biliary surgeries)
b. Diagnosis: noncrampy, epigastic pain; radiates to left or right upper quadrant, or to the back; fever; tachycardia; nausia and vomiting; elevated WBC, serum amylase and lipase; LFTs elevated in severe cases; CT is best test
c. Differential diagnosis: acute chole, perforated gastric ulcer, mesenteric ischemia, esophageal perforation, MI
d. Sequellae: chronic pancreatitis; outcome correlated to Ranson’s criteria; hypocalcemia; renal failure; pancreatic necrosis (<30% of tissue will resolve w/o treatment); infection and abscess have 40% mortality
e. Treatment:
i. Medical: IV fluids due to 3rd spacing into retroperitoneum; antibiotics for gallstone pancreatitis (not useful in other kinds);
ii. Surgical: diagnostic laprotomy; gallstone removal in severe cases
II. Chronic Pancreatitis
a. Pathology: EtOH is most common; can be due to ductal damage; also cystic fibrosis, familial pancreatitis, or pancreatic divisum (failure for buds to fuse)
b. Diagnosis: intermittant pain until scarring and fibrosis causes incessant pain; B12 deficiency; CT scan is best test;
c. Differential diagnosis:
d. Sequellae: steatorrhea, fat malabsorption when pancreatic function is <10%; diabetes
e. Treatment:
i. Medical: low-fat diet; avoid EtOH; enzyme replacement
ii. Surgical: decompress “chain of lakes” duct into jejunum
III. Pseudocysts
a. Pathology: collections of pancreatic juices; lined by non-epithelial cells (typically fibrotic)
b. Diagnosis: epigastric pain, can be with nausia/vomiting; history of pancreatitis and jaundice; weight loss; persistantly elevated serum amylase, lipase; CT or ultrasound are good tests
c. Differential diagnosis:
d. Sequellae: infection (must be drained); hemorrhage into cyst (can be lethal); erosion into major vessel (also not good);
e. Treatment:
i. Medical: 30% resolve spontaneously when NPO;
ii. Surgical: after fibrotic wall forms, create fistula to stomach or jejunum; drain if symptomatic after 4-6 weeks;
IV. Pancreatic adenoma:
a. Pathology: 2/3rds in the head (Whipple candidates);
b. Diagnosis: correlated to smoking, but not to pancreatitis or EtOH; weight loss, jaundice and constant pain in the posterior epigastric radiating to the back; palpable, nontender gallbladder (Courvoisier’s sign); ultrasound for right upper quadrant, CT for visualizing pancreas;
c. Differential diagnosis:
d. Sequellae: mets to liver or peritoneal seeding; repairs often leak due to lipase; survival is poor regardless of treatment (<12 months);
e. Treatment:
i. Medical: vitamin K replacement due to liver injury;
ii. Surgical: Whipple for pancreatic head cancers; distal pancreatectomy if in tail; unresectable if mets to liver
V. Cystadenoma: typically in tail of pancreas in middle-aged women; best prognosis than adenoma
VI. Islet cell tumors
a. Insulinoma: Whipple’s triad: fasting, blood sugar <50, eating relieves symptoms;
b. Gastrinoma: Zollinger-Ellison
i. Pathology: excess gastrin
ii. Diagnosis: ulcers in strange places, recurrent duodenal ulcers, watery diarrhea or large gastric rugae; secretin test to confirm;
iii. Differential diagnosis: could be part of MEN
iv. Sequellae:
v. Treatment: find and remove tumor